DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Milger K, Kneidinger N, Neurohr C. et al.
Switching to nintedanib after discontinuation of pirfenidone due to adverse events in IPF.
Eur Respir J 2015;
46: 1217-1221
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.